KA
Karen Akinsanya
DELAYED 1 MONTH
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Schrodinger, Inc.
Filings
2
Companies
1
Latest
Mar 5, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
62
SDGRCLUSTER 6
Schrodinger, Inc.
Karen Akinsanya
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Sale
$17.6K
1,366 sh
Mar 6 10:27 PM
Mar 5, 2026
54
SDGRCLUSTER 2
Schrodinger, Inc.
Karen Akinsanya
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Sale
$26.5K
2,206 sh
Mar 3 9:31 PM
Mar 2, 2026